Citations

Mayo Clinic

Showing 10 of 108523 citations.

Fusobacterium-Positive and Streptococcal-Positive Pharyngitis
Uhl, James R., Gustafson, Daniel R., Rucinski, Stefanea L., Patel, Robin , Patel, Robin

Annals of Internal Medicine | June 15, 2015 | Volume: 162 | Issue: 12 | Pages: 876-877

10.7326/l15-5099-2 | PMID 26075767 Get It

Where to Go Now With V-Go?
Thompson, Bithika , Thompson, Bithika M, Cook, Curtiss B.

Journal of Diabetes Science and Technology | June 15, 2015 | Volume: 9 | Issue: 5 | Pages: 1117-1118

10.1177/1932296815590155 | PMID 26078256 Get It

V-Go™ is a mechanical continuous insulin delivery device releasing a basal amount of rapid acting insulin that also allows the user the ability to deliver discrete meal time or correction doses. This analysis reviews available published literature on the technology, and discusses a recent article comparing the V-Go system with multiple daily insulin injection therapy. Finally, suggestions for future studies are provided.
Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration
Burger, Charles D.

Annals of the American Thoracic Society | June 15, 2015 | Volume: 12 | Issue: 6 | Pages: 959-959

10.1513/annalsats.201503-114le | PMID 26075561 Get It

Cancer Caregiver: Perceived Benefits of Technology
Atherton, Pamela J., Clark, Matthew M. , Kung, Simon , Sloan, Jeff A. , Rummans, Teresa A. , Lapid, Maria I. , Atherton, Pamela J.

Telemedicine and e-Health | June 15, 2015 | Volume: 21 | Issue: 11 | Pages: 893-902

10.1089/tmj.2014.0117 | PMID 26075800 Get It

Background: The burden associated with caregiving has been well documented. Caregivers have multiple responsibilities, and technology may be accessible as a potential burden-alleviating resource. Materials and Methods: We surveyed cancer caregivers regarding current technology use and willingness to use technology for easing burden or distress. Because age has been associated with technology use, responses were compared between geriatric (≥65 years old) and nongeriatric (18–64 years old) caregivers. Results: We had 112 respondents. Based on nonmissing responses, 66% ( n =71) were women, 95% ( n =106) were white, and 84% ( n =91) had post–high school education. Almost all caregivers reported having Internet (105 [94%]) and e-mail (102 [91%]) access. Nongeriatric caregivers indicated more willingness to access Internet-based tools that help caregivers (54 [93%] versus 41 [76%]; p =0.04) and were more frequent users of social media (37 [64%] versus 16 [30%]; p =0.01), smartphones (33 [57%] versus 16 [30%]; p =0.01), and other mobile wireless devices (42 [72%] versus 19 [35%]; p <0.001) than geriatric caregivers. They also more frequently expected technologies to improve their own quality of life ( p =0.009), increase their feelings of being effective as a caregiver ( p =0.02), and save time ( p =0.003). Regardless of age, a majority of caregivers (67 [62%]) endorsed the potential benefit of caregiving technologies in preventing burnout. Conclusions: Most caregivers have high access to and use of technology. Geriatric and nongeriatric caregivers were receptive to technology-based tools to help with their caregiving roles. Although nongeriatric caregivers expected to derive more benefit from such tools, both groups believed that caregiving technologies could reduce burden.
Is Endobronchial Ultrasound Influenced by Sedation Strategy? Comparing Apples to Apples
Sasieta, Humberto C., Mandrekar, Jay , Maldonado, Fabien , Sasieta, Humberto

American Journal of Respiratory and Critical Care Medicine | June 15, 2015 | Volume: 191 | Issue: 12 | Pages: 1469-1470

10.1164/rccm.201503-0508le | PMID 26075428 Get It

Systematic review: colitis associated with anti‐CTLA‐4 therapy
Felice, Kara M. De, Loftus, Edward V. , Khanna, Sahil , Gupta, Arjun , Loftus, Edward V

Alimentary Pharmacology & Therapeutics | June 15, 2015 | Volume: 42 | Issue: 4 | Pages: 406-417

10.1111/apt.13281 | PMID 26079306 Get It

SummaryBackgroundCytotoxic T‐lymphocyte‐associated protein‐4 (CTLA‐4) has an important role in T‐cell regulation, proliferation and tolerance. Anti‐CTLA‐4 agents, such as ipilimumab and tremelimumab, have been shown to prolong overall survival in patients with metastatic melanoma, and their use is being investigated in the treatment of other malignancies. Their novel immunostimulatory mechanism, however, predisposes patients to immune‐related adverse effects, of which gastrointestinal effects such as diarrhoea and colitis are the most common.AimsTo discuss the existing literature and summarise the epidemiology, pathogenesis and clinical features of anti‐CTLA‐4‐associated colitis, and to present a management algorithm for it.MethodsWe searched PubMed for studies published through October 2014 using the terms ‘anti‐CTLA,’ ‘ipilimumab,’ ‘tremelimumab,’ ‘colitis,’ ‘gastrointestinal,’ ‘immune‐related adverse effect,’ ‘immunotherapy,’ ‘melanoma,’ and ‘diarrhoea.’ResultsWatery diarrhoea is commonly associated with anti‐CTLA‐4 therapy (27–54%), and symptoms occur within a few days to weeks of therapy. Diffuse acute and chronic colitis are the most common findings on endoscopy (8–22%). Concomitant infectious causes of diarrhoea must be evaluated. Most cases may be successfully managed with discontinuation of anti‐CTLA‐4 and conservative therapy. Those with persistent grade 2 and grade 3/4 diarrhoea should undergo endoscopic evaluation and require corticosteroid therapy. Corticosteroid‐resistant cases may respond to anti‐tumour necrosis factor‐alpha therapy such as infliximab. Surgery is reserved for patients with bowel perforation or failure of medical therapy.ConclusionGiven the increasing use of anti‐CTLA‐4 therapy, clinicians must be aware of related adverse events and their management.
Direct Pulmonary Vein Ablation With Stenosis Prevention Therapy
Holmes, David R. , Ebrille, Elisa , Syed, Faisal F. , Ladewig, Dorothy J., Mikell, Susan B. , Powers, Joanne, Suddendorf, Scott H., Gilles, Emily J., Danielsen, Andrew J., Hodge, David O. , Asirvatham, Samuel J. , Kapa, Suraj , DeSimone, Christopher V. , Asirvatham, Samuel J

Journal of Cardiovascular Electrophysiology | June 15, 2015 | Volume: 26 | Issue: 9 | Pages: 1000-1006

10.1111/jce.12732 | PMID 26075706 Get It

Direct Pulmonary Vein Ablation With Stenosis Prevention TherapyIntroductionThe dominant location of electrical triggers for initiating atrial fibrillation (AF) originates from the muscle sleeves inside pulmonary veins (PVs). Currently, radiofrequency ablation (RFA) is performed outside of the PVs to isolate, rather than directly ablate these tissues, due to the risk of intraluminal PV stenosis.MethodsIn 4 chronic canine experiments, we performed direct PV muscle sleeve RFA ± postablation drug‐coated balloon (DCB) treatment with paclitaxel/everolimus. Of the 4 PVs, 2 PVs were ablated and treated with DCB, 1 PV was ablated without DCB treatment (positive control), and 1 PV was left as a negative control. Local electrograms were assessed in PVs for near‐field signals and were targeted for ablation. After 12–14 weeks survival, PVs were interrogated for absence of near‐field PV potentials, and each PV was assessed for stenosis.ResultsAll canines survived the study period without cardiorespiratory complications, and remained ambulatory. In all canines, PVs that were ablated and treated with DCB remained without any significant intraluminal stenosis. In contrast, PVs that were ablated and not treated with DCB showed near or complete intraluminal stenosis. At terminal study, PV potentials remained undetectable. A blinded, histologic analysis demonstrated that ablated PVs without DCB treatment had extensive thrombus, fibrin, mineralization, and elastin disruption.ConclusionOur chronic canine data suggest that direct PV tissue ablation without subsequent stenosis is feasible with the use of postablation DCBs.
Disappointing reliability of pulsatility indices to identify candidates for magnetic resonance imaging screening in population-based studies assessing prevalence of cerebral small vessel disease
Brutto, Óscar H. Del , Mería, Robertino M., Andrade, María de la Luz, Castillo, Pablo R. , Zambrano, Mauricio, Nader, Juan A. , Mera, Robertino M. , Castillo, Pablo R

Journal of Neurosciences in Rural Practice | June 15, 2015 | Volume: 6 | Issue: 03 | Pages: 336-338

10.4103/0976-3147.158760 | PMID 26167015 Get It

ABSTRACT Background: Diagnosis of cerebral small vessel disease (SVD) is a challenge in remote areas where magnetic resonance imaging (MRI) is not available. Hospital-based studies in high-risk or stroke patients have found an association between the pulsatility index (PI) of intracranial arteries - as derived from transcranial Doppler (TCD) - and white matter hyperintensities (WMH) of presumed vascular origin. We aimed to assess the reliability of cerebral pulsatility indices to identify candidates for MRI screening in population-based studies assessing prevalence of SVD. Methods: A representative sample of stroke-free Atahualpa residents aged ≥65 years investigated with MRI underwent TCD. Using generalized linear models, we evaluated whether the PI of major intracranial arteries correlate with WMH (used as a proxy of diffuse SVD), after adjusting for demographics and cardiovascular risk factors. Results: Out of 70 participants (mean age 70.6 ± 4.6 years, 57% women), 28 (40%) had moderate-to-severe WMH. In multivariate models, there were no differences across categories of WMH in the mean PI of middle cerebral arteries (1.10 ± 0.16 vs. 1.22 ± 0.24, β: 0.065, 95% confidence interval (CI): −0.084-0.177, P = 0.474) or vertebrobasilar arteries (1.11 ± 0.16 vs. 1.29 ± 0.27, β: 0.066, 95% CI: −0.0024-0.156, P = 0.146). Conclusions: Cerebral PI should not be used to identify candidates for MRI screening in population-based studies assessing the burden of SVD.
Incorporating the Last Four Digits of Social Security Numbers Substantially Improves Linking Patient Data from De‐identified Hospital Claims Databases
Naessens, James M. , Visscher, Sue L. , Swanson, Kristi M. , Johnson, Matthew G. , Rahman, Parvez, Schindler, Joe, Sonneborn, M, Pine, Michael , Peterson, Stephanie M, Rahman, Parvez A, Peterson, Stephanie M. Peck , Fry, Donald E.

Health Services Research | June 15, 2015 | Volume: 50 | Issue: S1 | Pages: 1339-1350

10.1111/1475-6773.12323 | PMID 26073819 Get It

ObjectiveAssess algorithms for linking patients across de‐identified databases without compromising confidentiality.Data Sources/Study SettingHospital discharges from 11 Mayo Clinic hospitals during January 2008–September 2012 (assessment and validation data). Minnesota death certificates and hospital discharges from 2009 to 2012 for entire state (application data).Study DesignCross‐sectional assessment of sensitivity and positive predictive value (PPV) for four linking algorithms tested by identifying readmissions and posthospital mortality on the assessment data with application to statewide data.Data Collection/Extraction MethodsDe‐identified claims included patient gender, birthdate, and zip code. Assessment records were matched with institutional sources containing unique identifiers and the last four digits of Social Security number (SSNL4).Principal FindingsGender, birthdate, and five‐digit zip code identified readmissions with a sensitivity of 98.0 percent and a PPV of 97.7 percent and identified postdischarge mortality with 84.4 percent sensitivity and 98.9 percent PPV. Inclusion of SSNL4 produced nearly perfect identification of readmissions and deaths. When applied statewide, regions bordering states with unavailable hospital discharge data had lower rates.ConclusionAddition of SSNL4 to administrative data, accompanied by appropriate data use and data release policies, can enable trusted repositories to link data with nearly perfect accuracy without compromising patient confidentiality. States maintaining centralized de‐identified databases should add SSNL4 to data specifications.
Evaluation of radiofrequency safety by high temperature resolution MR thermometry using a paramagnetic lanthanide complex
Dharmadhikari, Shalmali , James, J.R. , Nyenhuis, J.A. , Bansal, Navin, James, Judy R

Magnetic Resonance in Medicine | June 15, 2015 | Volume: 75 | Issue: 5 | Pages: 2121-2129

10.1002/mrm.25792 | PMID 26073056 Get It